Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease

Singh, Ajay K., Szczech, Lynda, Tang, Kezhen L., Barnhart, Huiman, Sapp, Shelly, Wolfson, Marsha, Reddan, Donal·2006·New England Journal of Medicine
DOI 10.1056/nejmoa065485

Cited by (1,002)

Items 801–900 of 1,002

  1. Perceptions and use of the national kidney foundation KDOQI guidelines: a survey of U.S. renal healthcare providers
    Michelle M. Estrella, Bernard G. Jaar, Kerri L. Cavanaugh, Chester H. Fox, Mark Anthony Perazella, Sandeep S. Soman, Emily Howell, Michael V. Rocco, Michael Jin Choi · 2013 · BMC Nephrology
  2. The effect of epoetin dose on hematocrit
    David Cotter, Y. Zhang, Mae Thamer, James S. Kaufman, Miguel Ángel Hernán · 2007 · Kidney International
  3. Management of the Diabetic Patient with Advanced Chronic Kidney Disease
    Radica Z. Alicic, Katherine R. Tuttle · 2010 · Seminars in Dialysis
  4. Changes in erythropoiesis-stimulating agent (ESA) dosing and haemoglobin levels in US non-dialysis chronic kidney disease patients between 2005 and 2009
    Deborah L. Regidor, William M. McClellan, Reshma Kewalramani, Amit Kumar Sharma, Brian D. Bradbury · 2010 · Nephrology Dialysis Transplantation
  5. Prevalence and Determinants of Anemia in Older People With Diabetes Attending an Outpatient Clinic: A Cross-Sectional Audit
    Katie Trevest, H. Treadway, Gerlineke Hawkins-van der Cingel, Claire Bailey, Ahmed H. Abdelhafiz · 2014 · Clinical Diabetes
  6. Anemia in chronic kidney disease patients: treatment recommendations and emerging therapies
    Lucia Del Vecchio, Francesco Locatelli · 2014 · Expert Review of Hematology
  7. Warning Flags for Erythropoiesis-Stimulating Agents and Cancer-Associated Anemia
    Terence R.J. Lappin, Alexander Peter Maxwell, Patrick G. Johnston · 2007 · The Oncologist
  8. Funding for Medical Education: Maintaining a Healthy Separation From Industry
    Jerry Avorn, Niteesh K. Choudhry · 2010 · Circulation
  9. Associations of Community Water Lead Concentrations with Hemoglobin Concentrations and Erythropoietin-Stimulating Agent Use among Patients with Advanced CKD
    Danziger, John, Mukamal, Kenneth J., Weinhandl, Eric · 2021 · Journal of the American Society of Nephrology
  10. Evaluation of arterial structure and function in pediatric patients with end‐stage renal disease on dialysis and after renal transplantation
    Hanan K. Tawadrous, Haroon Kamran, Louis F. Salciccioli, Morris J. Schoeneman, Jason Lazar · 2012 · Pediatric Transplantation
  11. Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trial
    Alistair Nichol, Craig French, Lorraine Little, Jeffrey Presneill, David James Cooper, Samir H. Haddad, Jacques Duranteau, Olivier Huet, Markus B. Skrifvars, Yaseen M. Arabi et al. · 2015 · Trials
  12. Anti-glycophorin single-chain Fv fusion to low-affinity mutant erythropoietin improves red blood cell-lineage specificity
    N. D. Taylor, Jeffrey C. Way, Pamela A. Silver, Pablo Cironi · 2010 · Protein Engineering Design and Selection
  13. Contrast-Induced Nephropathy and Long-Term Clinical Outcomes Following Percutaneous Coronary Intervention in Patients With Advanced Renal Dysfunction (Estimated Glomerular Filtration Rate <30 ml/min/1.73 m2)
    Yosuke Negishi, Akihito Tanaka, Hideki Ishii, Kensuke Takagi, Yosuke Inoue, Yusuke Uemura, Norio Umemoto, Naoyuki Yoshioka, Itsuro Morishima, Hiroshi Asano et al. · 2018 · The American Journal of Cardiology
  14. Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD
    Francesco Locatelli, Thierry P. Hannedouche, Steven N. Fishbane, Zoe Morgan, Delphine Oguey, William B. White · 2019 · Clinical Journal of the American Society of Nephrology
  15. Hypoxia-inducible factor prolyl hydroxylase inhibitor in the treatment of anemia in chronic kidney disease
    Yu Kurata, Tetsuhiro Tanaka, Masaomi Nangaku · 2020 · Current Opinion in Nephrology & Hypertension
  16. Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies
    Jonathan Barratt, Frank Dellanna, José María Portolés, Gabriel J. Choukroun, Luca De Nicola, James Young, Nada B. Dimkovic, Michael Reusch · 2023 · Advances in Therapy
  17. Anemia and Hypoxia Impact on Chronic Kidney Disease Onset and Progression: Review and Updates
    Elmukhtar M. Habas, Aisha Al Adab, Mehdi Arryes, Gamal B. Alfitori, Khalifa L Farfar, Ala M Habas, Raza Ali Akbar, Amnna Rayani, Eshrak Habas, Abdulnaser Elzouki · 2023 · Cureus
  18. Anaemia management in patients with chronic kidney disease: T aiwan practice guidelines
    Szu‐Chun Hung, Ko‐Lin Kuo, Der‐Cherng Tarng, Chih‐Cheng Hsu, Kwan‐Dun Wu, Tung‐Po Huang · 2014 · Nephrology
  19. Beyond Anemia: The Clinical Impact of the Physiologic Effects of Erythropoietin
    Charles J. Diskin, Thomas J. Stokes, Linda M. Dansby, Lautrec Radcliff, Thomas B. Carter · 2008 · Seminars in Dialysis
  20. Trends in Renal Replacement Therapy in Turkey, 1996-2008
    Gültekin Süleymanlar, Kamıl Serdengeçtı, Mehmet Rıza Altıparmak, Kitty J. Jager, Nurhan Seyahi, Ekrem Erek · 2011 · American Journal of Kidney Diseases
  21. Hemoglobin Level Variability: Anemia Management among Variability Groups
    David T. Gilbertson, Yi Peng, Brian D. Bradbury, James P. Ebben, Allan J. Collins · 2009 · American Journal of Nephrology
  22. Treatment of Anaemia with Erythropoiesis-Stimulating Agents in Patients with Chronic Kidney Disease Does Not Lower Mortality and May Increase Cardiovascular Risk: A Meta-Analysis
    José Vinhas, C. Barreto, José Assunção, Leonor Parreira, Álefe Fernandes Vaz · 2012 · Nephron Clinical Practice
  23. Cardiovascular risk factors and prevention of cardiovascular disease in patients with chronic renal disease
    Bernardo Rodríguez‐Iturbe, Ricardo Correa‐Rotter · 2010 · Expert Opinion on Pharmacotherapy
  24. Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: a systematic review
    Sergio Leonardi, Paul W. Armstrong, Phillip J. Schulte, E. Magnus Ohman, Laura Kristin Newby · 2013 · European Heart Journal
  25. Hemoglobin Variability with Epoetin Beta and Continuous Erythropoietin Receptor Activator in Patients on Peritoneal Dialysis
    Nicholas M. Selby, Sally Fonseca, Richard Fluck, Maarten W. Taal · 2011 · Peritoneal Dialysis International
  26. Impact of individual intravenous iron preparations on the differentiation of monocytes towards macrophages and dendritic cells
    Lisa H. Fell, Sarah Seiler-Mußler, Alexander B. Sellier, Björn Rotter, Peter Winter, Martina Sester, Danilo Fliser, Gunnar Henrik Heine, Adam M. Zawada · 2016 · Nephrology Dialysis Transplantation
  27. When is a guideline not a guideline? The devil is in the details
    Lisa Cosgrove, Allen F. Shaughnessy, Terrence M. Shaneyfelt · 2018 · BMJ Evidence-Based Medicine
  28. ESA, Iron Therapy and New Drugs: Are There New Perspectives in the Treatment of Anaemia?
    Lucia Del Vecchio, Roberto Minutolo · 2021 · Journal of Clinical Medicine
  29. Continuous EPO receptor activator therapy of anemia in children under peritoneal dialysis
    Francisco J Cano, Claudia Alarcon, Marta A. Azocar, Carolina Lizama, Ana María Lillo, Ángela Delucchi, Mariluz González, Patricia Arellano, Iris Delgado, Maria Teresa Droguett · 2011 · Pediatric Nephrology
  30. Malnutrition-inflammation-atherosclerosis syndrome in Chronic Kidney disease
    Pragna Rao, G. Chinnapu Reddy, A. S. Kanagasabapathy · 2008 · Indian Journal of Clinical Biochemistry
  31. Factor analysis of various anaerobic power tests.
    J M Manning, CATHRYN R. DOOLY-MANNING, David H. Perrin · 1988 · PubMed
  32. Guidelines Have Done More Harm than Good
    Richard Amerling, James Frank Winchester, Claudio Ronco · 2008 · Blood Purification
  33. Editorial: The Optimal Hemoglobin in Dialysis Patients— A Critical Review
    Ajay K. Singh, Steven Fishbane · 2007 · Seminars in Dialysis
  34. Anemia of Chronic Kidney Disease
    Ajay K. Singh · 2007 · Clinical Journal of the American Society of Nephrology
  35. Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients
    Noritaka Kawada, Toshiki Moriyama, Naotsugu Ichimaru, Ryoichi Imamura, Isao Matsui, Yoshitsugu Takabatake, Yasuyuki Nagasawa, Yoshitaka Isaka, Yasuyuki Kojima, Y Kokado et al. · 2009 · Clinical and Experimental Nephrology
  36. Effect of Medicare Dialysis Payment Reform on Use of Erythropoiesis Stimulating Agents
    Shailender Swaminathan, Vincent Mor, Rajnish Mehrotra, Amal N. Trivedi · 2014 · Health Services Research
  37. Determining Optimum Hemoglobin Sampling for Anemia Management from Every-Treatment Data
    Adam E. Gawęda, Brian Harris Nathanson, Alfred A. Jacobs, George R. Aronoff, Michael J. Germain, Michael E. Brier · 2010 · Clinical Journal of the American Society of Nephrology
  38. Eisenmangel, Thrombozytose und Thromboembolie
    Rayko Evstatiev · 2016 · Wiener Medizinische Wochenschrift
  39. Asymmetric Dimethylarginine Contributes to the Impaired Response to Erythropoietin in CKD-Anemia
    Miyuki Yokoro, Yosuke Nakayama, Sho‐ichi Yamagishi, Ryotaro Ando, Miki Sugiyama, Sakuya Ito, Junko Yano, Kensei Taguchi, Yusuke Kaida, Daisuke Saigusa et al. · 2017 · Journal of the American Society of Nephrology
  40. Hematocrit and Stroke: A Forgotten and Neglected Link?
    Konstantinos Stavropoulos, Konstantinos P. Imprialos, Chrysoula Boutari, Michael N. Doumas, Sofia Bouloukou · 2017 · Seminars in Thrombosis and Hemostasis
  41. Associations of cerebral oxygenation with hemoglobin levels evaluated by near-infrared spectroscopy in hemodialysis patients
    Susumu Ookawara, Kiyonori Ito, Yusuke Sasabuchi, Hideyuki Hayasaka, Masaya Kofuji, Takayuki Uchida, Keita Horigome, Sojiro Imai, Toshiko Akikawa, Noriko Wada et al. · 2020 · PLoS ONE
  42. Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors on iron regulation in non-dialysis-dependent chronic kidney disease patients with anemia: A systematic review and meta-analysis
    Jing Li, Qionghong Xie, Li You, Ningxin Xu, Chuan‐Ming Hao · 2020 · Pharmacological Research
  43. Factors Affecting Doses of Roxadustat Versus Darbepoetin Alfa for Anemia in Nondialysis Patients
    Tadao Akizawa, Keiko Tanaka‐Amino, Tetsuro Otsuka, Yusuke Yamaguchi · 2021 · American Journal of Nephrology
  44. New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: a multicohort observational study
    Roberto Minutolo, Michele Provenzano, Paolo Chiodini, Silvio Borrelli, Carlo Garofalo, Michele Andreucci, Maria Elena Liberti, Vincenzo Bellizzi, Giuseppe Conte, Luca De Nicola et al. · 2022 · Clinical Kidney Journal
  45. Erythropoietin Combined with ACE Inhibitor Prevents Heart Remodeling in 5/6 Nephrectomized Rats Independently of Blood Pressure and Kidney Function
    Nadezda Gut, Grzegorz Piecha, Firas Aldebssi, Sebastian Markus Schaefer, Raffi Bekeredjian, Peter Schirmacher, Eberhard Ritz, Marie-Luise Groß-Weißmann · 2013 · American Journal of Nephrology
  46. Anemia is a predictor of graft loss but not cardiovascular events and all‐cause mortality in renal transplant recipients: follow‐up data from the ALERT study
    Patrick Schjelderup, Dag Olav Dahle, Hallvard Holdaas, Geir Mjøen, G. Nordby, Sadollah Abedini, Alan G. Jardine, Bengt Fellström, My Hanna Sofia Svensson · 2013 · Clinical Transplantation
  47. Health‐related quality of life in the era of erythropoietin
    Steven Darrow Weisbord, Paul L. Kimmel · 2008 · Hemodialysis International
  48. Prevention of Chronic Kidney Disease and Subsequent Effect on Mortality: A Systematic Review and Meta-Analysis
    Usman Khan, Amit X. Garg, Chirag R. Parikh, Steven G. Coca · 2013 · PLoS ONE
  49. A randomized, double-blind, placebo-controlled study to assess the effect of recombinant human erythropoietin on functional outcomes in anemic, critically ill, trauma subjects: the Long Term Trauma Outcomes Study
    Fred A. Luchette, Michael D. Pasquale, Timothy C. Fabian, Wayne K. Langholff, Marsha Wolfson · 2011 · The American Journal of Surgery
  50. The Role of Anemia Management in Improving Outcomes for African-Americans with Chronic Kidney Disease
    Janice P. Lea, Keith C. Norris, Lawrence Y C Agodoa · 2008 · American Journal of Nephrology
  51. Current Perspectives on Protective Roles of Erythropoietin in Cardiovascular System: Erythropoietin Receptor as a Novel Therapeutic Target
    Yutaka Kagaya, Yasuhide Asaumi, Wanting “Lisa” Wang, Morihiko Takeda, Makoto Nakano, Kimio Satoh, Yoshihiro Fukumoto, Hiroaki Shimokawa · 2012 · The Tohoku Journal of Experimental Medicine
  52. Postmortem serum erythropoietin levels in establishing the cause of death and survival time at medicolegal autopsy
    Quan Li, Bao-Li Zhu, Takaki Ishikawa, Tomomi Michiue, Dong Hui Zhao, David Li, M. Ogawa, Hajime Maeda · 2008 · International Journal of Legal Medicine
  53. An expert opinion on the current treatment of anemia in patients with kidney disease
    Francesco Locatelli, Lucia Del Vecchio · 2012 · Expert Opinion on Pharmacotherapy
  54. Methodology of a reevaluation of cardiovascular outcomes in the RECORD trial: Study design and conduct
    Renato D. Lópes, Sheila Dickerson, Gail E. Hafley, Shana Burns, Sandra Tourt-Uhlig, Jennifer White, Laura Kristin Newby, Michel Komajda N, John J.V. McMurray, Robert Bigelow et al. · 2013 · American Heart Journal
  55. Pharmacotherapy for Mechanical Circulatory Support: A Comprehensive Review
    Christopher R. Ensor, Christopher A. Paciullo, William D. Cahoon, Paul E. Nolan · 2011 · Annals of Pharmacotherapy
  56. Patient Safety Issues in CKD: Core Curriculum 2015
    Lee-Ann Wagner, Asha L. Tata, Jeffrey Craig Fink · 2015 · American Journal of Kidney Diseases
  57. Hemoglobin concentration and the risk of hemorrhagic and ischemic stroke in patients undergoing hemodialysis: the Q-cohort study
    Ryusuke Yotsueda, Shigeru Tanaka, Masatomo Taniguchi, Kiichiro Fujisaki, Kumiko Torisu, Kosuke Masutani, Hideki Hirakata, Takanari Kitazono, Kazuhiko Tsuruya · 2017 · Nephrology Dialysis Transplantation
  58. Impact of Transferrin Saturation on All-Cause Mortality in Patients on Maintenance Hemodialysis
    Madoka Sato, Norio Hanafusa, Ken Tsuchiya, Hiroshi Kawaguchi, Kosaku Nitta · 2019 · Blood Purification
  59. Machine learning in nephrology: scratching the surface
    Qi Li, Qiuling Fan, Qiuxia Han, Wenjia Geng, Huanhuan Zhao, Xiaonan Ding, Jing-Yao Yan, Hanyu Zhu · 2020 · Chinese Medical Journal
  60. A recurrent neural network approach to predicting hemoglobin trajectories in patients with End-Stage Renal Disease
    Benjamin J. Lobo, Emaad M. Abdel‐Rahman, Donald E. Brown, Lori Dunn, Brendan T. Bowman · 2020 · Artificial Intelligence in Medicine
  61. Anemia of Critical Illness
    Kwame Asare · 2008 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  62. Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)
    Jodie L. Babitt, Jeffrey S. Berns, Biykem Bozkurt, Rebecca S. Cheung Khedairy, Yarieli Cuevas, Emmanuel E. Effa, Michele Freerk Eisenga, Steven Fishbane, Yelena Z. Ginzburg, Volker H. Haase et al. · 2026 · Kidney International
  63. Treatment with high dose of erythropoiesis-stimulating agents and mortality: analysis with a sequential Cox approach and a marginal structural model
    M. Suttorp, Tiny Hoekstra, Moshe Mittelman, Ilka Ott, Raymond Theodorus Krediet, Friedo Wilhelm Dekker, Hein Putter · 2015 · Pharmacoepidemiology and Drug Safety
  64. Implementing Quality Measures for Inflammatory Bowel Disease
    Shahzad Ahmed, Corey Allan Siegel, GIL Y. MELMED · 2015 · Current Gastroenterology Reports
  65. Erythropoietin and the vascular wall: The controversy continues
    WOLFGANG E. B. JELKMANN, Steve Elliott · 2012 · Nutrition Metabolism and Cardiovascular Diseases
  66. Impact of a Clinical Pharmacy Anemia Management Service on Adherence to Monitoring Guidelines, Clinical Outcomes, and Medication Utilization
    Jenny M. Debenito, Sarah J. Billups, Thu S. Tran, Lea C. Price · 2014 · Journal of Managed Care Pharmacy
  67. Treatment of Anemia in Kidney Disease: Beyond Erythropoietin
    Jay B. Wish · 2021 · Kidney International Reports
  68. Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease
    Mark J. Koury, Rajiv Agarwal, Glenn Matthew Chertow, Kai‐Uwe Eckardt, Steven N. Fishbane, Tomas Ganz, Volker H. Haase, Mark R. Hanudel, Patrick S. Parfrey, Pablo E. Pérgola et al. · 2022 · American Journal of Hematology
  69. Health-Related Quality of Life in Dialysis Patients with HCV Infection
    Fabrizio Fabrizi, Piergiorgio Messa, Paul B. Martin · 2009 · The International Journal of Artificial Organs
  70. Prevalence and determinants of anemia in the immediate postkidney transplant period
    Ruben Poesen, Bert Bammens, Kathleen J. Claes, Dirk R. J. Kuypers, Yves F. Ch. Vanrenterghem, Diethard R.L. Monbaliu, Pieter Evenepoel · 2011 · Transplant International
  71. Erythropoiesis-Stimulating Agents
    Steve Elliott · 2010 · Cancer treatment and research
  72. Anemia correction by erythropoietin reduces BNP levels, hospitalization rate, and NYHA class in patients with cardio-renal anemia syndrome
    Alberto Palazzuoli, Ilaria Quatrini, Anna Calabrò, Giovanni Antonelli, Maria Caputo, Maria Stella Campagna, Beatrice Franci, Ranuccio Nuti · 2010 · Clinical and Experimental Medicine
  73. Effectiveness and safety of erythropoiesis-stimulating agent use in the perioperative period
    Diane HD Tran, Gordon TC Wong, Yee Eot Chee, Michael G. Irwin · 2013 · Expert Opinion on Biological Therapy
  74. Cardiorenal Syndrome Type 4: Management
    Anna Clementi, Grazia Maria Virzì, Alessandra Brocca, Massimo de Cal, Giorgio Vescovo, Antonio Raffaele Michele Granata, Claudio Ronco · 2013 · Blood Purification
  75. Haemoglobin levels and health-related quality of life in young and elderly patients on specialized predialysis care
    Moniek C.M. de Goeij, Yvette Meuleman, Sandra van Dijk, Diana Carina Grootendorst, Friedo Wilhelm Dekker, Nynke Halbesma, for the PREPARE-2 Study Group · 2014 · Nephrology Dialysis Transplantation
  76. Erythropoietin Increases Expression and Function of Transient Receptor Potential Canonical 5 Channels
    Ying Liu, Yunfei Xu, Florian Thilo, Ulla Glenert Friis, Boye Lagerbon Jensen, Alexandra Scholze, Junhua Zheng, Martin Tepel · 2011 · Hypertension
  77. Serum Erythropoietin Level and Mortality in Kidney Transplant Recipients
    Miklos Zsolt Molnar, Ádám Gyula Tabák, Ahsan Alam, Maria Eszter Czira, Anna Rudas, Ákos Újszászi, Gabriella Bekő, Márta Novák, Kamyar Kalantar‐Zadeh, Csaba Pal Kovesdy et al. · 2011 · Clinical Journal of the American Society of Nephrology
  78. Anemia of chronic kidney disease
    Fouad Kutuby, Sarah Wang, Chaitanya Desai, Edgar V. Lerma · 2015 · Disease-a-Month
  79. Spectrum of anemia after kidney transplantation: pathophysiology and therapeutic implications
    Oluwatoyin Fatai Bamgbola · 2016 · Clinical Transplantation
  80. Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation
    Amy Barton Pai · 2017 · Annals of the New York Academy of Sciences
  81. Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial
    Shubhadeep D. Sinha, Vamsi Krishna Bandi, Bala Reddy Bheemareddy, Pankaj Thakur, Sreenivasa Chary, Kalpana S. Mehta, Vikranth Reddy Pinnamareddy, Rajendra Prasad Pandey, Subhramanyam Sreepada, Santosh Durugkar · 2019 · BMC Nephrology
  82. Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation
    Laura T. Pizzi, Thomas J. Bunz, Daniel W. Coyne, David S. Goldfarb, Ajay K. Singh · 2008 · Kidney International
  83. The Controversy Surrounding Hemoglobin and Erythropoiesis-Stimulating Agents: What Should We Do Now?
    Ajay K. Singh · 2008 · American Journal of Kidney Diseases
  84. Recombinant human erythropoietins, biosimilars and immunogenicity
    Huub Schellekens · 2008 · Journal of Nephrology
  85. Iron, oxidative stress, and clinical outcomes
    Rajiv Agarwal · 2007 · Pediatric Nephrology
  86. Cardiovascular events in chronic dialysis patients: emphasizing the importance of vascular disease prevention
    Kosmas I. Paraskevas, Ioannis Kotsikoris, Sotirios A. Koupidis, Alexandros A. Tzovaras, Dimitri P. Mikhailidis · 2010 · International Urology and Nephrology
  87. Daprodustat and Heart Failure in CKD
    Jonathan W. Cunningham, Brian Lee Claggett, Renato D. Lópes, John J.V. McMurray, Vlado Perkovic, Kevin Carroll, Thomas F. Hiemstra, Kaivan Khavandi, Mary Ann Lukas, Prerna R. Ranganathan et al. · 2024 · Journal of the American Society of Nephrology
  88. Anaemia and quality of life in chronic kidney disease: a consensus document from the European Anaemia of CKD Alliance
    Indranil Dasgupta, Corinne Isnard Bagnis, Matteo Floris, Hans Furuland, Daniel Gallego Zurro, Loreto Gesualdo, Nathalie Heirman, Roberto Minutolo, Antonello Pani, José María Portolés et al. · 2024 · Clinical Kidney Journal
  89. Chronic Kidney Disease
    Morgan Erika Grams, Michal L. Melamed · 2025 · Annals of Internal Medicine
  90. IRON THERAPY IN CHRONIC KIDNEY DISEASE: CURRENT CONTROVERSIES
    Csaba Pal Kovesdy, Kamyar Kalantar‐Zadeh · 2009 · Journal of Renal Care
  91. Clinical Factors and the Decision to Transfuse Chronic Dialysis Patients
    Cynthia B. Whitman, Sanatan Shreay, Matthew D. Gitlin, Martijn G.H. van Oijen, Brennan Mason Ross Spiegel · 2013 · Clinical Journal of the American Society of Nephrology
  92. Interventions for erythropoietin-resistant anaemia in dialysis patients
    Sunil V. Badve, Elaine Beller, Alan Cass, Daniel Peter Francis, Carmel Mary Hawley, Iain C. Macdougall, Vlado Perkovic, David Wayne Johnson · 2013 · Cochrane Database of Systematic Reviews
  93. Artificial intelligence for optimal anemia management in end-stage renal disease
    Michael E. Brier, Adam E. Gawęda · 2016 · Kidney International
  94. TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the Liver
    Sota Kato, Nagahiro Ochiai, Hiroki Takano, Fusayo Io, Noriko Takayama, Hiroko Koretsune, Ei-ichi Kunioka, Saeko Uchida, Koji Yamamoto · 2019 · Journal of Pharmacology and Experimental Therapeutics
  95. Heart Failure Hospitalization in Adults Receiving Hemodialysis and the Effect of Intravenous Iron Therapy
    Pardeep S. Jhund, Mark Colquhoun Petrie, Michele Robertson, Patrick Barry Mark, Michael Ross MacDonald, Eugene C. Connolly, Stefan D. Anker, Sunil Bhandari, Ken Farrington, Philip A. Kalra et al. · 2021 · JACC Heart Failure
  96. Safe and Effective Treatment for Anemic Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis on Roxadustat
    Mei Tang, Changyu Zhu, Ting Yan, Yanglin Zhou, Qin Lv, Junlan Chuan · 2021 · Frontiers in Pharmacology
  97. The efficacy and safety of roxadustat for the treatment of anemia in non-dialysis dependent chronic kidney disease patients: An updated systematic review and meta-analysis of randomized clinical trials
    Basel Abdelazeem, Joseph Shehata, Kirellos Said Abbas, Nahla Ahmed El‐Shahat, Bilal Haider Malik, Pramod K. Savarapu, Mostafa M. Eltobgy, Arvind R. Kunadi · 2022 · PLoS ONE
  98. Molidustat for the treatment of renal anaemia in patients with non-dialysis-dependent chronic kidney disease: design and rationale of two phase III studies
    Hiroyasu Yamamoto, Megumi Taguchi, Yoshimi Matsuda, Kazuma Iekushi, Takashi Yamada, Tadao Akizawa · 2019 · BMJ Open
  99. Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study
    Ichiei Narita, Terumasa Hayashi, Shoichi Maruyama, Takao Masaki, Masaomi Nangaku, Tomoya Nishino, Hiroshi Satō, Tadashi Sofue, Takashi Wada, Enyu Imai et al. · 2022 · PLoS ONE
  100. Risk factors for high erythropoiesis stimulating agent resistance index in pre-dialysis chronic kidney disease patients, stages 4 and 5
    Ana Cabrita, Ana Pinho, Anabela Malho Guedes, Elsa Morgado, Marília Faísca, Hermínio Carrasqueira, Ana Paula Silva, Pedro Leão Neves · 2010 · International Urology and Nephrology